Maricarmen D. Planas-Silva All publications ( 9 ) Planas-Silva MD. Hamilton KN. Targeting c-Src kinase enhances tamoxifen's inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins. 2007 Sep. Cancer Chemother Pharmacol. 60(4):535-43. Planas-Silva MD. Bruggeman RD. Grenko RT. Smith JS. Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer. 2007 Feb. Exp Mol Pathol. 82(1):85-90. Witters LM. Witkoski A. Planas-Silva MD. Berger M. Viallet J. Lipton A. Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor. 2007 Feb. Oncol Rep. 17(2):465-9. Planas-Silva MD. Filatova IS. Estrogen-dependent regulation of Eg5 in breast cancer cells. 2007 Aug. Anticancer Drugs. 18(7):773-9. Planas-Silva MD. Waltz PK. Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells. 2007 Apr. J Steroid Biochem Mol Biol. 104(1-2):11-21. Planas-Silva MD. Bruggeman RD. Grenko RT. Stanley Smith J. Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer. 2006 Mar 3. Biochem Biophys Res Commun. 341(1):73-81. Planas-Silva MD. Waltz PK. Kilker RL. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant. 2006 Mar. J Steroid Biochem Mol Biol. 98(4-5):193-8. Kilker RL. Planas-Silva MD. Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells. 2006 Dec 1. Cancer Res. 66(23):11478-84. Kilker RL. Hartl MW. Rutherford TM. Planas-Silva MD. Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells. 2004 Sep. J Steroid Biochem Mol Biol. 92(1-2):63-71.